KCNQ2 and epilepsy: In this regard, they have been increasingly used in the clinical practice as add-on treatments in early-onset epilepsies, and it should be noted that few reports are today available specifically on KCNQ2-related neonatal epilepsies trialed with VitB6 (either in its inactive or active form) with variable outcomes (Table 1).